These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2159814)

  • 21. Clinical pharmacology of pipecuronium in infants and children during halothane anesthesia.
    Sarner JB; Brandom BW; Dong ML; Pickle D; Cook DR; Weinberger MJ
    Anesth Analg; 1990 Oct; 71(4):362-6. PubMed ID: 2169211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinicopharmacology of Arduan].
    Mészáros C
    Acta Pharm Hung; 1992 May; 62(3):133-8. PubMed ID: 1354406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of the action of pipecuronium bromide in patients under halothane anesthesia--a comparison with pancuronium bromide regarding their neuromuscular blocking and cardiovascular effects].
    Sugai N; Yajima C; Numata K; Irimada T; Hashimoto Y; Itagaki T; Katsumata N; Suzuki H; Aoki T; Fukushima K
    Masui; 1990 Mar; 39(3):293-300. PubMed ID: 2161058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newer neuromuscular blocking drugs. An overview of their clinical pharmacology and therapeutic use.
    Mirakhur RK
    Drugs; 1992 Aug; 44(2):182-99. PubMed ID: 1382013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuromuscular effect of pipecuronium bromide in infants and children during nitrous oxide-alfentanil anesthesia.
    Pittet JF; Tassonyi E; Morel DR; Gemperle G; Rouge JC
    Anesthesiology; 1990 Mar; 72(3):432-5. PubMed ID: 2155549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On some properties of a new steroid curare-like compound pipecurium bromide.
    Alyautdin RN; Buyanov VV; Fisenko VP; Lemina EJ; Muratov VK; Samoilov DN; Shorr VA
    Arzneimittelforschung; 1980; 30(2a):355-7. PubMed ID: 6248077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacologic effects of pipecuronium bromide (Arduan)].
    Kárpáti E; Bíró K
    Acta Pharm Hung; 1992 May; 62(3):121-6. PubMed ID: 1323913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study with Arduan and Alloferin.
    Takács G
    Ther Hung; 1984; 32(3):119-22. PubMed ID: 6100829
    [No Abstract]   [Full Text] [Related]  

  • 29. Pipecurium bromide (Arduan)--new steroid non-depolarizing muscle relaxant.
    Kobielski J; Wysocki M; Orlicz P; Trzaski M; Gajewski K
    Ther Hung; 1986; 34(1):45-9. PubMed ID: 2833823
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of respiratory and metabolic alkalosis and acidosis on pipecuronium neuromuscular block.
    Biró K
    Eur J Pharmacol; 1988 Sep; 154(3):329-33. PubMed ID: 2853060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of the steroid muscle relaxant arduan in surgical interventions on the musculoskeletal system].
    Pashchuk AIu; Tiutiunnik IF; Zgola IA
    Ortop Travmatol Protez; 1984 Dec; (12):20-2. PubMed ID: 6098888
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacological study of a new competitive neuromuscular blocking steroid, pipecurium bromide.
    Kárpáti E; Biró K
    Arzneimittelforschung; 1980; 30(2a):346-57. PubMed ID: 6155921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experience with Arduan in anaesthesiology.
    Kovács L
    Ther Hung; 1984; 32(2):65-8. PubMed ID: 6100821
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of dalargin on some parameters of peroxidation of liver lipids in experimental animals].
    Shloznikov BM; Korotkina RN; Babkina NV; Karelin AA; Fomchenkov EP
    Biull Eksp Biol Med; 1990 Dec; 110(12):609-10. PubMed ID: 2083360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A dose-response evaluation of pipecuronium bromide in elderly patients under balanced anesthesia.
    Azad SS; Larijani GE; Goldberg ME; Beach CA; Marr AT; Seltzer JL
    J Clin Pharmacol; 1989 Jul; 29(7):657-9. PubMed ID: 2547848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Respiration paralysing and circulatory effects of a new non-depolarizing relaxant, pipecurium bromide, in anaesthetized dogs.
    Pulay I; Alánt O; Darvas K; Weltner J; Zétény Z
    Arzneimittelforschung; 1980; 30(2a):358-60. PubMed ID: 6248078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacokinetics, urinary and biliary excretion of pipecuronium bromide.
    Wierda JM; Szenohradszky J; De Wit AP; Zentai G; Agoston S; Kakas M; Kleef UW; Meijer DK
    Eur J Anaesthesiol; 1991 Nov; 8(6):451-7. PubMed ID: 1662599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arduan, a new neuromuscular blocking agent.
    Fister T
    Ther Hung; 1983; 31(3):117-9. PubMed ID: 6100827
    [No Abstract]   [Full Text] [Related]  

  • 39. Neuromuscular effects of pipecuronium bromide.
    Stanley JC; Mirakhur RK; Bell PF; Sharpe TD; Clarke RS
    Eur J Anaesthesiol; 1991 Mar; 8(2):151-6. PubMed ID: 1651856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of dalargin on proliferative processes and vertical migration of cells of the corneal epithelium during stress].
    Timoshin SS; Berezhnova NI; Shvets SI
    Biull Eksp Biol Med; 1990 Feb; 109(2):189-91. PubMed ID: 2337661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.